Suraksha Diagnostic Limited (NSE:SURAKSHA)

Market Cap	16.31B +5.0%
Revenue (ttm)	3.14B +24.4%
Net Income	321.87M +1.1%
EPS	6.18 +3.5%
Shares Out	52.08M
PE Ratio	50.68
Forward PE	40.68
Dividend	n/a
Ex-Dividend Date	n/a

Volume	142,956
Average Volume	50,129
Open	320.10
Previous Close	320.10
Day's Range	291.10 - 322.30
52-Week Range	224.10 - 352.50
Beta	n/a
RSI	63.70
Earnings Date	May 21, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,300
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SURAKSHA

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.14 billion, an increase of 24.39% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.